Clinical trial · Observational
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for Hepatocellular Carcinoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Currently, there are few studies on the diagnostic ability of CEUS-LI-RADS in patients with non-high risk factors for liver nodules. Whether this classification is applicable to such patients remains controversial. There are relatively few studies on the diagnostic efficacy of HCC in clinical diagnosis and the consistency between map readers, and the applicable population is only focused on patients with hepatic fibrosis. Therefore, this study explored the application value of CEUS Li-RADS in liver focal lesions in patients with non-high risk factors for hepatocellular carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SonoVue | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Experimental group
- description
- 1. patients with hepatic focal lesions 2. patients with non-high risk factors for hepatocellular carcinoma
- interventionNames
- Diagnostic Test: SonoVue
Primary outcomes (4)
- measure
- Positive Predictive Value
- timeFrame
- 3 years
- description
- The positive predictive value of LR-5 diagnosis of HCC was compared among different map readers
- measure
- Negative Predictive Value
- timeFrame
- 3 years
- description
- The negative predictive value of LR-5 diagnosis of HCC was compared among different map readers
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The patient showed focal liver lesions on routine ultrasound examination. * Non-HCC high-risk patients (hepatitis B, cirrhosis) Exclusion Criteria: * High-risk patients with HCC (hepatitis B, cirrhosis); * Patients with solid liver tumors could not be found by conventional imaging; * Patients who do not sign informed consent;
References
Publications (0)
Data not yet available